{"id":34464,"date":"2026-06-05T14:17:29","date_gmt":"2026-06-05T18:17:29","guid":{"rendered":"https:\/\/cdtrp.ca\/vers-limmunite-et-au-dela-11-juin-2026\/"},"modified":"2026-06-05T14:17:29","modified_gmt":"2026-06-05T18:17:29","slug":"vers-limmunite-et-au-dela-11-juin-2026","status":"publish","type":"post","link":"https:\/\/cdtrp.ca\/fr\/vers-limmunite-et-au-dela-11-juin-2026\/","title":{"rendered":"Vers l’immunit\u00e9 et au-del\u00e0 – 11 juin, 2026"},"content":{"rendered":"

<\/a><\/span><\/div>
<\/div>

Vers l\u2019immunit\u00e9 et au del\u00e0<\/strong><\/h4>\n
Le PRDTC est heureux de pr\u00e9senter une s\u00e9rie de 13 webinaires con\u00e7ue pour diffuser la recherche en immunologie financ\u00e9e par les IRSC, favoriser le partage des connaissances et renforcer la collaboration au sein des communaut\u00e9s canadiennes de l\u2019immunit\u00e9, du don et de la transplantation. Une s\u00e9rie virtuelle nationale visant \u00e0 diffuser des recherches de pointe en immunologie \u00e0 l\u2019intersection de l\u2019immunit\u00e9, de l\u2019infection, du don d\u2019organes et de la transplantation.<\/h5>\n
La s\u00e9rie comprend deux webinaires d\u2019introduction portant sur des notions fondamentales en immunologie, destin\u00e9s aux non-sp\u00e9cialistes (offerts en format bilingue), ainsi que onze webinaires scientifiques principaux mettant en valeur soit des collaborations entre chercheurs en milieu et en fin de carri\u00e8re et des stagiaires, soit des chercheurs en d\u00e9but de carri\u00e8re.<\/h5>\n<\/div>
<\/div>
<\/i>Visitez le site web<\/span><\/a><\/div><\/div><\/div><\/div><\/div>
<\/a><\/span><\/div><\/div>
<\/div>
<\/div>
<\/div>
Le 11 juin 2026<\/strong>, nous aurons le plaisir d\u2019accueillir le Dr Ian Rogers<\/strong>, professeur \u00e0 l\u2019Universit\u00e9 de Toronto (D\u00e9partement d\u2019obst\u00e9trique et gyn\u00e9cologie et D\u00e9partement de physiologie) et chercheur au Lunenfeld-Tanenbaum Research Institute, accompagn\u00e9 de son \u00e9tudiant \u00e0 la ma\u00eetrise, Ryan Wu<\/strong>, de l\u2019Universit\u00e9 de Toronto. Ils pr\u00e9senteront leurs travaux de recherche intitul\u00e9s : \u00abInduction of tolerance to bone marrow grafts by Trogocytosis<\/strong><\/h5>\n<\/div>
<\/div>
<\/div>
<\/div>
<\/i>Inscription<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div>
\"Image<\/span><\/div><\/div><\/div>

\u00e0 propos du Dr. Ian Rogers<\/strong><\/h4>\n
\n

Dr. Rogers is a Professor at the University of Toronto (Dept of Obstetrics and Gynecology, Dept of Physiology) and Scientist at the Lunenfeld-Tanenbaum Research Institute. He graduated with his PhD from the University of Toronto. His thesis focused on early embryo development. He completed his Post Doc with Robert Casper (University of Toronto) developing cell therapies using umbilical cord blood cells to treat spinal cord injury, peripheral vascular disease and diabetic skin wounds.<\/p>\n

Started at the Lunenfeld-Tanenbaum Research Institute , Mt. Sinai Hospital in 2004 with a research focus on Stem Cells.<\/p>\n

Dr. Rogers\u2019 lab is focused on developing therapies three dimensional tissue culture systems to improve stem cell therapies. By combining stem cells with decellularized organs his aim is to advance studies on stem cell differentiation, cell-cell signaling and understanding the complex three-dimensional organization of cells into functional organs and tissues. Dr. Rogers is also the Scientific Founder of Insception Lifebank, a Stem Cell Bank Company.<\/p>\n<\/div>\n<\/div><\/div><\/div>

\"Image<\/span><\/div><\/div><\/div>

\u00e0 propos de Ryan Wu<\/strong><\/h4>\n
\n

I graduated this year from the University of Toronto with majors in physiology as well as cell and molecular biology. I first joined the Rogers lab as a 4th year research student where I investigated the properties and mechanism of trogocytosis in human and mouse MSC co-cultures. This has fostered my passion for researching bone marrow stem cells and motivated me to pursue a master\u2019s degree where I will be expanding on this project. Our goal is to further screen for enhancers of trogocytosis and assess their applicability to in-vivo transplant models.<\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":34458,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37,81],"tags":[],"class_list":["post-34464","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee","category-en-vedette"],"_links":{"self":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/34464"}],"collection":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/comments?post=34464"}],"version-history":[{"count":2,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/34464\/revisions"}],"predecessor-version":[{"id":34466,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/34464\/revisions\/34466"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/media\/34458"}],"wp:attachment":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/media?parent=34464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/categories?post=34464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/tags?post=34464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}